{
    "title": "Biogen tops 3Q expectations as cost cutting continues",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11352713/Biogen-tops-3Q-expectations-cost-cutting-continues.html",
    "date": "2022-10-25",
    "keywords": [
        "biogen",
        "treatment",
        "quarter",
        "tecfidera",
        "share",
        "forecast",
        "cost",
        "drugmaker",
        "balance",
        "maker",
        "sclerosis",
        "research",
        "development",
        "gain",
        "building",
        "sale",
        "revenue",
        "inc",
        "cambridge",
        "year",
        "tuesday",
        "office",
        "space",
        "total",
        "income",
        "spinraza",
        "disorder",
        "headquarters",
        "mass",
        "ap",
        "photosteven",
        "file",
        "drug",
        "program",
        "spending",
        "aduhelm",
        "part",
        "costcutting",
        "plan",
        "range",
        "july"
    ],
    "category": [
        "wires",
        "ap"
    ]
}